Synageva Biopharma Corp.
Q3 2014 13F Holders
Symbol
GEVA
CUSIP
87159A103
Type
Equity
Class
COM
Num filings
125
Total reported value, excl. options
$2.44 B
Compare 2014 Q3 to
2015 Q1
2014 Q4
2014 Q2
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type